Athens Research and Technology
Private Company
Funding information not available
Overview
Athens Research and Technology is a long-established, private biotechnology company that operates as a specialized supplier and service provider in the proteomics and antibody sectors. Its core business is the purification and manufacture of high-quality human and animal proteins, which are critical reagents for academic research, pharmaceutical proof-of-concept studies, and diagnostic kit manufacturing. The company emphasizes its ISO9001:2015 certified facility, custom purification services, and direct-to-customer sales model, positioning itself as a trusted partner for high-purity biological materials. It is preparing for a rebranding under a new name effective April 2026.
Technology Platform
Expertise in purification of proteins from native human and animal sources (plasma, erythrocytes, neutrophils, tissues) using chromatography and other biochemical techniques. Specializes in low-endotoxin and immunogen-grade proteins.
Opportunities
Risk Factors
Competitive Landscape
Competes with large, diversified life science reagent suppliers (e.g., Thermo Fisher, Merck) and specialized recombinant protein producers. Its differentiation lies in its expertise with native protein purification, offering post-translationally modified proteins that are critical for certain research and diagnostic applications.